Published in
Elsevier, The Lancet, 9936(383), p. 2222-2231, 2014
DOI: 10.1016/s0140-6736(14)60084-2
Links
Tools
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Journal article published in 2014 by
Bonaventura Clotet,
Judith Feinberg,
Jan van Lunzen,
Marie-Aude Khuong-Josses,
Andrea Antinori,
Irina Dumitru,
Vadim Pokrovskiy,
Jan Fehr 
,
Roberto Ortiz,
Michael Saag,
Julia Harris,
Clare Brennan,
Tamio Fujiwara,
Sherene Min
,
Roberto Ortiz,
Michael Saag,
Julia Harris,
Clare Brennan,
Tamio Fujiwara,
Sherene Min
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 